GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
- Written by PR Newswire
![]() |
- Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology
- Novel IgG Blocker eliminates heterophilic antibody interference, ensuring clinical-grade purity and mitigating thromboembolic risks
YONGIN, South Korea, April 6, 2026 /PRNewswire/ -- GC Biopharma (006280.KS), a global...















